德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

交易中 07-30 10:22:51

5.550

-0.070

-1.25%

最高5.740	最低5.400	成交量243.35万
今开5.620	昨收5.620	日振幅6.05%
总市值37.68亿	流通市值37.68亿	总股本6.79亿
成交额1,349万	换手率0.36%	流通股本6.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":5.55,"timestamp":1753842115367,"preClose":5.62,"halted":0,"volume":2433500,"delay":0,"floatShares":679000000,"shares":679000000,"eps":-0.5627750935066566,"marketStatus":"交易中","change":-0.07,"latestTime":"07-30 10:22:51","open":5.62,"high":5.74,"low":5.4,"amount":13492570,"amplitude":0.060498,"askPrice":5.55,"askSize":11500,"bidPrice":5.53,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":-0.5627750935066566,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1753848000000},"marketStatusCode":2,"adr":0,"listingDate":1605801600000,"exchange":"SEHK","adjPreClose":5.62,"openAndCloseTimeList":[[1753839000000,1753848000000],[1753851600000,1753862400000]],"volumeRatio":1.512929,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"2555034318","title":"德琪医药-B07月29日获主力加仓433.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555034318","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555034318?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:15","pubTimestamp":1753776957,"startTime":"0","endTime":"0","summary":"07月29日, 德琪医药-B股价涨1.63%，报收5.62元，成交金额4880.7万元，换手率1.25%，振幅6.69%，量比0.81。德琪医药-B今日主力资金净流入433.0万元，连续6日净流入，上一交易日主力净流入162.5万元。该股近5个交易日上涨29.16%，主力资金累计净流入1721.3万元；近20日主力资金累计净流入3570.6万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729170249a6c78681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729170249a6c78681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06996","BK1191"],"gpt_icon":0},{"id":"2555085892","title":"港股异动 | 德琪医药-B(06996)盘中涨超3% 希维奥用于治疗多发性骨髓瘤获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2555085892","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555085892?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:06","pubTimestamp":1753754809,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德琪医药-B(06996)盘中涨超3%，截至发稿，涨1.63%，报5.62港元，成交额736.09万港元。消息面上，7月28日，德琪医药-B发布公告，中国国家药品监督管理局(NMPA) 已批准希维奥 (塞利尼索)(与硼替佐米和地塞米松(XVd)联用)用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者，这是希维奥的一种新适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 德琪医药-B(06996)盘中涨超3% 希维奥用于治疗多发性骨髓瘤获国家药监局批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2554721005","title":"德琪医药-B(06996)：希维奥®在中国获批用于多发性骨髓瘤的二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2554721005","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554721005?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:48","pubTimestamp":1753692491,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，中国国家药品监督管理局(NMPA) 已批准希维奥® (塞利尼索)(与硼替佐米和地塞米松(XVd)联用)用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者，这是希维奥®的一种新适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德琪医药-B(06996)：希维奥®在中国获批用于多发性骨髓瘤的二线治疗","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1191","06996"],"gpt_icon":0},{"id":"2554621747","title":"德琪医药-B盘中异动 早盘股价大涨5.02%报5.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554621747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554621747?lang=zh_cn&edition=full","pubTime":"2025-07-28 09:38","pubTimestamp":1753666719,"startTime":"0","endTime":"0","summary":"2025年07月28日早盘09时38分，德琪医药-B股票出现异动，股价快速拉升5.02%。截至发稿，该股报5.650港元/股，成交量104.5万股，换手率0.15%，振幅3.90%。资金方面，该股资金流入327.779万港元，流出237.612万港元。德琪医药-B股票所在的药品行业中，整体涨幅为2.42%。其相关个股中，泰凌医药、恒瑞医药、培力农本方涨幅较大，振幅较大的相关个股有联康生物科技集团、泰凌医药、恒瑞医药，振幅分别为6.61%、6.56%、5.14%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809383994be494a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809383994be494a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"2553428205","title":"德琪医药-B07月24日获主力加仓312.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553428205","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553428205?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344942,"startTime":"0","endTime":"0","summary":"07月24日, 德琪医药-B股价涨5.57%，报收4.93元，成交金额4302.0万元，换手率1.30%，振幅7.28%，量比0.59。德琪医药-B今日主力资金净流入312.6万元，连续3日净流入，上一交易日主力净流入304.3万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为66.67%，平均涨幅为15.76%。该股近5个交易日上涨30.00%，主力资金累计净流入2567.5万元；近20日主力资金累计净流入2259.8万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165751a6bf5089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165751a6bf5089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1191","BK1583","BK1574"],"gpt_icon":0},{"id":"2553121044","title":"Boyu Capital Group Holdings Ltd.减持德琪医药-B(06996)77.8万股 每股作价3.15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553121044","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553121044?lang=zh_cn&edition=full","pubTime":"2025-07-23 19:59","pubTimestamp":1753271964,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月18日，Boyu Capital Group Holdings Ltd.减持德琪医药-B(06996)77.8万股，每股作价3.15港元，总金额为245.07万港元。减持后最新持股数目约为6731.22万股，持股比例为9.91%。本次交易涉及其他关联方：Boyu Group, LLC、XYXY Holdings Ltd.、童小幪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06996","BK1191","BK1574","BK1583"],"gpt_icon":0},{"id":"2553078215","title":"德琪医药-B07月23日获主力加仓304.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553078215","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553078215?lang=zh_cn&edition=full","pubTime":"2025-07-23 16:15","pubTimestamp":1753258541,"startTime":"0","endTime":"0","summary":"07月23日, 德琪医药-B股价涨6.38%，报收4.67元，成交金额4059.9万元，换手率1.30%，振幅12.07%，量比0.63。德琪医药-B今日主力资金净流入304.3万元，上一交易日主力净流入372.9万元。该股近5个交易日上涨43.17%，主力资金累计净流入2173.0万元；近20日主力资金累计净流入1919.5万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723165835a45e75c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723165835a45e75c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"2553310902","title":"德琪医药-B07月22日主力净流入372.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553310902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553310902?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:15","pubTimestamp":1753172140,"startTime":"0","endTime":"0","summary":"07月22日, 德琪医药-B股价涨0.23%，报收4.39元，成交金额4864.6万元，换手率1.60%，振幅9.82%，量比0.90。德琪医药-B今日主力资金净流入372.9万元，上一交易日主力净流出86.1万元。该股近5个交易日上涨41.53%，主力资金累计净流入2017.1万元；近20日主力资金累计净流入1613.3万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170112a45be548&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170112a45be548&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06996","BK1574","BK1583"],"gpt_icon":0},{"id":"2553447038","title":"德琪医药-B盘中异动 早盘急速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553447038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553447038?lang=zh_cn&edition=full","pubTime":"2025-07-21 09:43","pubTimestamp":1753062201,"startTime":"0","endTime":"0","summary":"2025年07月21日早盘09时43分，德琪医药-B股票出现异动，股价大幅下跌5.15%。德琪医药-B股票所在的药品行业中，整体跌幅为0.07%。其相关个股中，精优药业、金嗓子、东瑞制药涨幅较大，振幅较大的相关个股有精优药业、德琪医药-B、开拓药业-B，振幅分别为10.23%、8.72%、8.17%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721094321a6b68133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721094321a6b68133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1191","BK1583","BK1574"],"gpt_icon":0},{"id":"2552455821","title":"德琪医药-B盘中异动 早盘股价大涨5.00%报3.990港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552455821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552455821?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:31","pubTimestamp":1752802298,"startTime":"0","endTime":"0","summary":"2025年07月18日早盘09时31分，德琪医药-B股票出现异动，股价大幅拉升5.00%。截至发稿，该股报3.990港元/股，成交量51.4万股，换手率0.08%，振幅4.74%。资金方面，该股资金流入124.562万港元，流出47.8955万港元。德琪医药-B股票所在的药品行业中，整体涨幅为0.47%。其相关个股中，泰凌医药、德琪医药-B、联康生物科技集团涨幅较大，振幅较大的相关个股有泰凌医药、德琪医药-B、绿叶制药，振幅分别为4.76%、4.74%、3.85%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718093138a4522ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718093138a4522ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2552617723","title":"交银国际：看好创新药板块 选股至关重要 料内地商保创新药目录落地或为相关支付长期呈数十倍增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2552617723","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552617723?lang=zh_cn&edition=full","pubTime":"2025-07-17 11:34","pubTimestamp":1752723267,"startTime":"0","endTime":"0","summary":"中国内地市场也同步显现复苏信号：2025年上半年二级市场医药板块估值快速修复形成明确拐点，显著提振投资者风险偏好，进而传导至一级市场交易活跃度提升。今年上半年中国内地融资总额同比反弹至41亿美元，已超越2024全年融资总额的56%。该行表示，依旧看好创新药板块整体继续修复的机会，但反弹后的选股至关重要。商业健康险未来增量空间值得期待，长期内保费和创新药支付规模有望呈数十倍增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","00013","159992","LU1720050803.USD","03329","BK1191","06996","BK1583","BK1587","IE00B5MMRT66.SGD","09926","IE00BPRC5H50.USD","06978","LU0417516571.SGD","IE00B543WZ88.USD","BK1588","BK1147","BK1574","LU0348783233.USD","02096","LU0348784397.USD","LU1794554557.SGD","BK1161"],"gpt_icon":0},{"id":"2551282361","title":"美股脑再生483倍泡沫破灭 vs 港股德琪501%价值重估：2025医药资本两极启示录","url":"https://stock-news.laohu8.com/highlight/detail?id=2551282361","media":"MedTrend医趋势","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551282361?lang=zh_cn&edition=full","pubTime":"2025-07-16 19:04","pubTimestamp":1752663870,"startTime":"0","endTime":"0","summary":"德琪医药以501%涨幅，位居港股第一。6月16日拆分正式生效后，盘中最高涨幅超4倍，股价单日暴涨283%，换手率达1.07%。另外，陈贤哲持有脑再生的98.89万股，占7.6%权益，为其第二大股东。截至2025年，该药物已在亚太地区8个市场获得上市批准，包括中国大陆、中国台湾、中国香港、中国澳门、韩国、新加坡、马来西亚和澳大利亚。5月20日，德琪医药宣布与默沙东达成全球临床合作，共同评估ATG-022联合默沙东PD-1抑制剂K药用于治疗晚期实体瘤患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716192314a44e9fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716192314a44e9fe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","RGC","BK4614","06996","YANG"],"gpt_icon":1},{"id":"2552245271","title":"德琪医药-B07月16日主力净流入148.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2552245271","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552245271?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:16","pubTimestamp":1752653763,"startTime":"0","endTime":"0","summary":"07月16日, 德琪医药-B股价涨2.88%，报收3.22元，成交金额1200.7万元，换手率0.56%，振幅7.99%，量比1.37。德琪医药-B今日主力资金净流入148.4万元，上一交易日主力净流出45.7万元。该股近5个交易日上涨5.56%，主力资金累计净流入12.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出141.3万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716171229a44e5894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716171229a44e5894&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2550610741","title":"德琪医药-B07月10日主力净流出54.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550610741","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550610741?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135346,"startTime":"0","endTime":"0","summary":"07月10日, 德琪医药-B股价跌0.33%，报收3.05元，成交金额833.1万元，换手率0.40%，振幅5.56%，量比1.00。德琪医药-B今日主力资金净流出54.1万元，上一交易日主力净流入18.9万元。该股近5个交易日上涨4.45%，主力资金累计净流出128.8万元；近20日主力资金累计净流出386.4万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165851a6a13a6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165851a6a13a6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2550687384","title":"德琪医药-B07月09日主力净流入18.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550687384","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550687384?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:15","pubTimestamp":1752048945,"startTime":"0","endTime":"0","summary":"07月09日, 德琪医药-B股价涨12.09%，报收3.06元，成交金额1432.3万元，换手率0.70%，振幅12.09%，量比2.18。德琪医药-B今日主力资金净流入18.9万元，上一交易日主力净流出93.5万元。该股近5个交易日上涨5.52%，主力资金累计净流出31.9万元；近20日主力资金累计净流出378.5万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170141a43ff55a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170141a43ff55a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"2550500579","title":"德琪医药亮相“格隆汇·中期策略会·2025”，空间位阻遮蔽技术TCE平台第一股大放异彩","url":"https://stock-news.laohu8.com/highlight/detail?id=2550500579","media":"格隆汇","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550500579?lang=zh_cn&edition=full","pubTime":"2025-07-09 14:11","pubTimestamp":1752041511,"startTime":"0","endTime":"0","summary":"德琪医药在资本市场的亮眼表现，源于其研发管线的驱动：第二代高壁垒TCE平台技术以及中后期全球同类最佳资产。技术突破和临床验证为公司长期发展注入强劲动力。","market":"us","thumbnail":"https://img2.gelonghui.com/b17e2-5b19ae56-0aaf-4f92-a2f7-7fb3923017d3.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-5b19ae56-0aaf-4f92-a2f7-7fb3923017d3.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2456828","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"1198706611","title":"港股异动丨无惧关税威胁，港股药品股大涨，恒瑞医药涨超7%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1198706611","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198706611?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:22","pubTimestamp":1752027740,"startTime":"0","endTime":"0","summary":"港股药品股集体拉升。","market":"hk","thumbnail":"https://static.tigerbbs.com/5c06e5fd3e3d300214034b8dd188058b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5c06e5fd3e3d300214034b8dd188058b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","01276","06996"],"gpt_icon":0},{"id":"2549596331","title":"德琪医药-B盘中异动 临近午盘快速下跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549596331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549596331?lang=zh_cn&edition=full","pubTime":"2025-07-08 11:35","pubTimestamp":1751945712,"startTime":"0","endTime":"0","summary":"2025年07月08日临近午盘11时35分，德琪医药-B股票出现异动，股价大幅跳水5.28%。德琪医药-B股票所在的药品行业中，整体涨幅为0.44%。其相关个股中，泰凌医药、君圣泰医药-B、四环医药涨幅较大，振幅较大的相关个股有精优药业、开拓药业-B、德琪医药-B，振幅分别为7.32%、6.92%、6.34%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708113512a43d1554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708113512a43d1554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1191","06996"],"gpt_icon":0},{"id":"2549065543","title":"德琪医药-B盘中异动 股价大跌5.00%报2.850港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549065543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549065543?lang=zh_cn&edition=full","pubTime":"2025-07-07 10:55","pubTimestamp":1751856913,"startTime":"0","endTime":"0","summary":"2025年07月07日早盘10时55分，德琪医药-B股票出现异动，股价快速下挫5.00%。截至发稿，该股报2.850港元/股，成交量57.05万股，换手率0.08%，振幅5.00%。资金方面，该股资金流入31.5335万港元，流出122.025万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.39%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070710551395390782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070710551395390782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06996","BK1574","BK1191"],"gpt_icon":0},{"id":"2548080911","title":"德琪医药-B07月03日主力净流入42.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2548080911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548080911?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530508,"startTime":"0","endTime":"0","summary":"07月03日, 德琪医药-B股价涨0.69%，报收2.92元，成交金额583.3万元，换手率0.29%，振幅3.45%，量比0.59。德琪医药-B今日主力资金净流入42.8万元，上一交易日主力净流出0万元。该股近5个交易日下跌10.64%，主力资金累计净流出163.6万元；近20日主力资金累计净流入85.0万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703165705a4ccf7dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703165705a4ccf7dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":0.2802},{"period":"1month","weight":0.9181},{"period":"3month","weight":0.8733},{"period":"6month","weight":6.2051},{"period":"1year","weight":8.8596},{"period":"ytd","weight":7.6462}],"compareEarnings":[{"period":"1week","weight":0.0157},{"period":"1month","weight":0.0511},{"period":"3month","weight":0.1539},{"period":"6month","weight":0.262},{"period":"1year","weight":0.4807},{"period":"ytd","weight":0.2724}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.083349},{"month":2,"riseRate":0.2,"avgChangeRate":0.354616},{"month":3,"riseRate":0.4,"avgChangeRate":0.022852},{"month":4,"riseRate":0.4,"avgChangeRate":-0.055669},{"month":5,"riseRate":0.6,"avgChangeRate":0.040777},{"month":6,"riseRate":0.2,"avgChangeRate":-0.111296},{"month":7,"riseRate":0.2,"avgChangeRate":0.025213},{"month":8,"riseRate":0.25,"avgChangeRate":-0.091947},{"month":9,"riseRate":0.25,"avgChangeRate":-0.038884},{"month":10,"riseRate":0.5,"avgChangeRate":0.098032},{"month":11,"riseRate":0.75,"avgChangeRate":0.10189},{"month":12,"riseRate":0.4,"avgChangeRate":0.02925}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}